ENBREL
etanercept
- Strength
- 50 mg/mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Immunex Corporation
ENBREL
etanercept
Listed by Immunex Corporation
- Strength
- 25 mg/.5mL
- Form
- Solution
- Route
- Subcutaneous
- Class
- Tumor Necrosis Factor Blocker
What it contains
- Etanercept 25 mg/.5mL
FDA record
| Dosage form | Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Tumor Necrosis Factor Blocker |
| Approval route | BLA — biologic licence |
| NDC code | 58406-055 |
| FDA application | BLA103795 |
| RxNorm concept | 253014 |
| Package sizes listed | 3 |
| Marketed since | March 2020 |
Other products containing Etanercept
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ENBREL
etanercept
- Strength
- 50 mg/mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Immunex Corporation
ENBREL
etanercept
- Strength
- 25 mg/.5mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Immunex Corporation
ENBREL
etanercept
- Strength
- 50 mg/mL
- Form
- Solution
- Class
- Tumor Necrosis Factor Blocker
Immunex Corporation
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.